🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single centre, three single administrations (Days 1, 29 and 57) a...
Status
Completed
Location
SGS Aster-Cephac
Start Date
2005-05
Trial ID
NCT00354861
This study is an open, exploratory clinical study to evaluate the safety an...
Status
Recruiting
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2022-06-01
Trial ID
NCT05410717
Treatments Being Tested
This study is investigating the optimal dose and the advantage in combining...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-08-30
Trial ID
NCT06290622
Treatments Being Tested
This is a first-in-human (FIH) phase 1 open-label, multicenter, multiple-do...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2021-10-06
Trial ID
NCT05101109
Treatments Being Tested
A Phase I open label, dose-escalation and expansion study to evaluate the s...
Status
Not Yet Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2024-12
Trial ID
NCT06691360
Treatments Being Tested
This phase II trial tests how well a combination of three immunotherapy dru...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-11-08
Trial ID
NCT06056895
This is the first study to test Sym022 in humans. The primary purpose of th...
Status
Completed
Location
South Texas Accelerated Research Therapeutics (START) Midwest
Start Date
2018-05-08
Trial ID
NCT03489369
Treatments Being Tested
This was an open-label, multicenter, nonrandomized Phase 1 and 2 clinical t...
Status
Completed
Location
Chao Family Comprehensive Cancer Center
Start Date
2018-11-13
Trial ID
NCT03744468
Treatments Being Tested
TQB2223 is a recombinant, fully humanized antibody that binds lymphocyte ac...
Status
Unknown
Location
Fujian Cancer Hospital
Start Date
2023-06-06
Trial ID
NCT05894421
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of ne...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center
Start Date
2021-05-28
Trial ID
NCT04658147
Treatments Being Tested